Lawrence Hineline - Intra Cellular Insider

ITCI -- USA Stock  

USD 21.08  0.46  2.14%

Mr. Lawrence J. Hineline, CPA, is the Chief Financial Officer, Vice President Finance, Treasurer, Assistant Secretary of IntraCellular Therapies, Inc. Mr. Hineline also served as the Secretary of the Company from August 2013 until September 2014. From December 2000 to November 2003, Mr. Hineline was the Vice President of Finance and Chief Financial Officer of Functional Genetics, Inc. Prior to that, Mr. Hineline served as the Vice President of Finance of North American Vaccine, Inc. and its predecessor companies from 1993 to 2000, and he served as Corporationrationrate Controller from 1989 to 1993. During this time, Mr. Hineline oversaw the growth of the accounting function and its systems for the company that emerged as a startup and was later acquired by Baxter Health Care
Age: 60  President Since 2014  CPA    
Hineline is a licensed CPA in the State of Maryland and received his Bachelor?s Degree from the University of Maryland Baltimore County.

Lawrence Hineline Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (21.78) % which means that it has lost $21.78 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (34.5) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 11 records


David MozleyEndocyte
Robert JanssenDynavax Technologies Corporatio
David JohnsonDynavax Technologies Corporatio
Alyssa WyantEdge Therapeutics
Bradford MiddlekauffEdge Therapeutics
Theodore AshburnDicerna Pharmaceuticals
Erik CheliusEndocyte
Michael BrinkleyEndocyte
Michael OstrachDynavax Technologies Corporatio
Kevin LaliberteDova Pharmaceuticals
Katherine ParkerEndocyte

Entity Summary

Intra-Cellular Therapies, Inc., a biopharmaceutical company, engages in developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases. Intra-Cellular Therapies, Inc. is headquartered in New York, New York. Intra Cellular operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 49 people.Intra Cellular Therapies (ITCI) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 49 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.

Intra Cellular Thera Leadership Team

Lawrence Wennogle, Vice President of Drug Discovery
Suresh Durgam, Senior Vice President Late Stage Clinical Development and Medical Affairs
Christopher Alafi, Director
Michael Rawlins, Director
Robert Nostrand, Independent Director
Richard Lerner, Director
Robert Davis, Senior Vice President and Chief Scientific Officer
Allen Fienberg, Co-Founder and VP of Bus. Devel.
Michael Halstead, Sr. VP, General Counsel and Secretary
Sharon Mates, Co-Founder, Chairman, CEO and Pres
Andrew Satlin, Executive Vice President and Chief Medical Officer
Juan Sanchez, Vice President - Corporate Communications and Investor Relations
Rory Riggs, Independent Director
Joel Marcus, Director
Kimberly Vanover, VP of Clinical Devel.
Lawrence Hineline, Vice President and CFO

Stock Performance Indicators

Did you try this?

Run Coins and Tokens Correlation Now


Coins and Tokens Correlation

Utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges
All  Next Launch Coins and Tokens Correlation

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.